Related Experiment Video

Updated: Feb 1, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

BH4 domain of Bcl-2 as a novel target for cancer therapy

Zhiqing Liu1, Christopher Wild1, Ye Ding1

  • 1Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA.

Drug Discovery Today
|December 4, 2015
PubMed

Insights

Targeting the BH4 domain of B cell lymphoma 2 (Bcl-2) proteins offers a novel strategy against cancer therapy resistance. This approach induces apoptosis and enhances treatment efficacy, presenting a promising new avenue for anticancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Overexpression of B cell lymphoma 2 (Bcl-2) proteins is linked to therapy resistance in human cancers.
  • Conventional treatments target the Bcl-2 homology (BH)3 domain.
  • The BH4 domain presents a unique and crucial structural target for novel anticancer strategies.

Purpose of the Study:

  • To review the structural and functional basis for targeting the BH4 domain of Bcl-2.
  • To highlight recent advancements in discovering small-molecule BH4 domain inhibitors.
  • To evaluate the therapeutic potential of BH4 domain inhibition in overcoming cancer resistance.

Main Methods:

  • Critical review of existing literature on Bcl-2 structure and function.
  • Analysis of drug discovery efforts focusing on BH4 domain inhibitors.
  • Evaluation of proof-of-concept studies for BH4-targeted therapies.

Main Results:

  • The BH4 domain's unique structure and cellular functions make it a superior therapeutic target.
  • Small-molecule inhibitors, such as BDA-366, are emerging as potential BH4-targeting drugs.
  • Preclinical data suggest BH4 domain targeting can induce apoptosis and overcome resistance.

Conclusions:

  • Targeting the BH4 domain of Bcl-2 is a promising strategy for novel anticancer therapies.
  • This approach has the potential to increase efficacy and overcome resistance in various cancers.
  • Further development of BH4 domain inhibitors could lead to improved cancer treatment outcomes.

More Related Videos

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K
Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

8.4K

Related Concept Videos

Three Developmental Domains01:29

Three Developmental Domains

Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
1.1K
Three-Domain System of Life01:21

Three-Domain System of Life

Ribosomal RNA (rRNA) sequence analysis revealed three distinct groups of cells: eukaryotes, bacteria, and archaea. In 1978, Carl R. Woese proposed the concept of domains, a taxonomic level above kingdoms, to differentiate these groups. He suggested that archaea and bacteria, despite their similar appearance, represent separate domains. Domains differ in rRNA, membrane lipid structure, transfer RNA, and antibiotic sensitivity.In this classification, animals, plants, and fungi belong to the...
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.4K
Membrane Domains01:18

Membrane Domains

The membrane domains concentrate specific lipids and proteins at one place within the membrane, which helps in cell signaling, adhesion, and other critical cellular processes. These domains can differ in size, composition, function, and lifespan.
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
7.2K